Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

First POC Genetic Test Diagnoses Lactose Intolerance Near Patient in Less Than 90 Minutes

By LabMedica International staff writers
Posted on 05 Sep 2023

Lactose intolerance is a medical condition marked by difficulty in digesting lactose due to reduced activity or synthesis of the enzyme lactase, which breaks down lactose into its basic sugars. More...

A specific genetic variant called the −13910 C/T single nucleotide polymorphism within the MCM6 gene is linked to lactase persistence or non-persistence traits in the Caucasian population. Diagnosing lactose intolerance is crucial for implementing dietary adjustments or appropriate treatments. Now, a new point-of-care isothermal lab-on-phone lactose intolerance assay rapidly diagnoses primary lactose intolerance using direct buccal swabs or capillary blood samples with high accuracy and at low cost.

STAB VIDA (Caparica, Portugal) has developed an isothermal lab-on-phone lactose intolerance CE-IVD (In Vitro Diagnostic) marked point-of-care diagnostic assay called STAB VIDA Lda which is based on the loop-mediated isothermal amplification (LAMP) methodology followed by mutation probe-based melting curve analysis. The assay is automatically processed in real time using the Doctor Vida system, an inexpensive and portable device controlled through a user-friendly mobile app. This CE-IVD portable, handheld device facilitates isothermal nucleic acid amplification for a wide range of genetic biomarkers. Combining efficiency, accuracy, and affordability, this compact lab-on-phone lactose intolerance detection assay can prove highly valuable in managing symptoms for individuals with lactose intolerance. Moreover, it differentiates between primary and secondary forms of hypolactasia, with the former arising from genetic mutations in the enhancer region and the latter resulting from small intestine damage.

In a study, researchers evaluated the POC isothermal lab-on-phone lactose intolerance assay using buccal swabs and capillary blood samples, comparing its performance with the Sanger sequencing assay that examined the -13,910 C/T SNP in blood samples. The assay's detection limit was also determined across different sample concentrations. The findings showed that the STAB VIDA Lda isothermal lactose intolerance assay effectively identified the -13910 C/T SNP with a limit of detection of five cells per assay, achieving 98.41% accuracy for buccal swabs and 100% accuracy for capillary blood samples. The entire process, from sample collection to result retrieval, was completed in just 90 minutes, with merely two minutes of hands-on time. The detection limit achieved by the STAB VIDA Lda assay was comparable to established gold-standard methods like Sanger sequencing and PCR-based assays.

Related Links:
STAB VIDA 


Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Homocysteine Quality Control
Liquichek Homocysteine Control
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.